GC Therapeutics
Boston
About GC Therapeutics
GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner. They have verified cells for several applications by dictating cell fates in a single step. They've also created SuperCells™ by customizing cells for certain conditions. Professor George Church's lab at Harvard Medical School is where GC Therapeutics' fundamental technology was developed, invented, and refined. They are a group of dedicated biologists and tissue engineers whose mission is to bring this ground-breaking method to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: gc-tx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gc-therapeutics-26330 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.